Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E5NY
|
||||
Former ID |
DIB014295
|
||||
Drug Name |
AZD-2423
|
||||
Synonyms |
CCR2b antagonist (pain, COPD), AstraZeneca
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
AstraZeneca plc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H29ClFN5O2
|
||||
InChI |
InChI=1S/C19H27ClFN5O2/c1-13(2)26-6-5-22-17(12-26)18(27)24-7-9-25(10-8-24)19(28)23-14-3-4-15(20)16(21)11-14/h3-4,11,13,17,22H,5-10,12H2,1-2H3,(H,23,28)/t17-/m1/s1
|
||||
InChIKey |
WERHXSXPOAOBJV-QGZVFWFLSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | C-C chemokine receptor type 2 | Target Info | Antagonist | [550850] | |
References | |||||
Ref 523197 | ClinicalTrials.gov (NCT01215279) AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD). U.S. National Institutes of Health. | ||||
Ref 542770 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7825). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.